Evaluate Retention of an Orally Administered Device Using Gamma Scintigraphy Study 2

NCT00780286 · clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
32
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Procter and Gamble